Guardant Health Co-CEO Talasaz Offloads $39.3 Million in Stock Amid Valuation Concerns
AmirAli Talasaz, co-chief executive officer and director at Guardant Health, Inc. (NASDAQ:GH), executed a series of transactions between June 26 and June 29, 2026, selling approximately $39.3 million in common stock while simultaneously acquiring shares through option exercises valued at roughly $1.1 million. The sales involved 260,000 shares trade…